Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times.

被引：0
|
作者：
Narra, A. [1 ]
Strasfeld, L. [2 ]
Basuli, D. [1 ]
Stack, M. [1 ]
Langewisch, E. [3 ]
Olyaei, A. [1 ]
Norman, D. [1 ,4 ]
Lockridge, J. [1 ,4 ]
机构：
[1] Oregon Hlth & Sci Univ, Transplant Nephrol, Portland, OR 97201 USA
[2] OHSU, Infect Dis, Portland, OR USA
[3] Univ Nebraska Med Ctr, Transplant Nephrol, Omaha, NE USA
[4] Portland VA, Transplant Nephrol, Portland, OR USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
185
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [31] POSITIVE EFFECTS OF CMV-IMMUNOGLOBULINS ON ANTIVIRAL CELLULAR IMMUNITY IN A KIDNEY TRANSPLANT RECIPIENT WITH MULTIDRUG-RESISTANT CMV-INFECTION
    Wiening, V.
    Schmidt, T.
    Dahmen, M.
    Reuter, S.
    Pavenstaedt, H.
    Sester, M.
    Suwelack, B.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 46 - 46
  • [32] Changes in cell-mediated immunity in kidney transplant recipients with active CMV infection
    Essa, S
    Raghupathy, R
    Pacsa, AS
    El-Shazly, A
    Said, T
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2002, 32 (03): : 199 - 204
  • [33] Protection from Cancer in Kidney Transplant Patients by γδ T Cells: Role of CMV Infection?
    Soderberg-Naucler, Cecilia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (01): : 11 - 13
  • [34] Rates of CMV Infection in Kidney Transplant Recipients Who Received Subtherapeutic Valganciclovir Prophylaxis
    Belfield, K.
    Cohen, E.
    Malinis, M.
    Baghban, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 514 - 514
  • [35] Differences in Risk For CMV or BK Infection After Kidney Transplant Based On Recipient Race
    Calderon, K.
    Taber, D.
    Kannabhiran, D.
    Pilch, N.
    Srinivas, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 552 - 552
  • [36] Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection
    Razeghi, E.
    Hadadi, A.
    Mansor-Kiaei, M.
    Molavi, M.
    Khashayar, P.
    Pourmand, G.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) : 993 - 996
  • [37] Comparison of Different Prophylactic Therapies for CMV Infection in High Risk Kidney and Kidney/Pancreas Transplant Recipients
    Raza, S. M.
    Balla, A.
    Bastnagel, W.
    Duhart, B. T., Jr.
    Krauss, A. G.
    Eason, J. D.
    Mya, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 143 - 143
  • [38] Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
    Litjens, Nicolle H. R.
    Huang, Ling
    Dedeoglu, Burc
    Meijers, Ruud W. J.
    Kwekkeboom, Jaap
    Betjes, Michiel G. H.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [39] Preemptive CMV Prophylaxis in Renal Transplant Recipients Receiving Everolimus Immunosuppression Reduces Cytomegalovirus Infection
    Spagnoletti, G.
    Salerno, M.
    Bianchi, V.
    Silvestrini, N.
    Apponi, F.
    Romagnoli, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 690 - 691
  • [40] Predicting pediatric kidney transplant wait times: The unexplored landscape and pre-allocation transplant policies
    Engen, Rachel M.
    PEDIATRIC NEPHROLOGY, 2024, 39 (08) : 2275 - 2278
12345